“Molecular-Docking Study of Quinazolin-4(3H)-One Derivatives Against GABAa Receptor Signifies the Novel Approach to Epilepsy Treatment”. International Journal of Pharmaceutical Sciences and Drug Research 12, no. 5 (September 30, 2020): 572–575. Accessed September 21, 2025. https://ijpsdronline.com/index.php/journal/article/view/1817.